Robert Z. Orlowski

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Robert Z. Orlowski
Apr 11, 2025, 15:47 | Blog
Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients
Muzaffar Qazilbash, Professor of Medicine at UT- MD Anderson Cancer Center, shared a post on…
Jan 17, 2025, 12:24 | Science
Myeloma Paper of the Day, January 17th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Analysis of MAIA study…
Jan 3, 2025, 13:22 | Science
Myeloma Paper of the Day, January 3rd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of standard-risk myeloma…
Dec 25, 2024, 17:52 | Blog
Rafael Fonseca: No one can guarantee outcome, but you can guarantee intent
Rafael Fonseca, Hematologist at Mayo Clinic, shared a post on X: "When writing treatment orders…
Dec 11, 2024, 19:11 | Drugs
Results of AQUILA Trial: Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Daratumumab, an anti-CD38 monoclonal antibody, has been approved for treating multiple myeloma. On December 9th…
Dec 10, 2024, 13:33 | Blog
Rahul Banerjee: Robert Z. Orlowski presented updated IMROZ MRD Multiple Myeloma data
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted on X: "ASH24 well, this…
Nov 12, 2024, 17:56 | Insight
Daratumumab+ Lenalidomide vs Lenalidomide for Post-Transplant Maintenance in Multiple Myeloma
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a recent article by…
Nov 2, 2024, 14:46 | Insight
Myeloma Paper of the Day, November 2nd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of optimal infused CD34+…
Oct 27, 2024, 17:41 | Blog
Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared on X: "S1803 Ph3…
Oct 26, 2024, 09:18 | Insight
Myeloma Paper of the Day, October 26th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Study of real-world outcomes of upfront ASCT…
Oct 18, 2024, 16:35 | Insight
Humberto Martinez-Cordero: Amazed by the incredible opportunity to be part of SWOG
Humberto Martinez-Cordero, Hematologist at the National Cancer Institute – ESE, shared a post on X:…
Oct 4, 2024, 15:20 | Insight
Rahul Banerjee: Dexamethasone 40mg weekly in Multiple Myeloma induction
Rahul Banerjee shared his recent article on X: "Grateful to Blood Journal, co-authors, and SWOG…
Sep 26, 2024, 13:50 | Insight
Myeloma Paper of the Day, September 26th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Cool paper from Rahul Banerjee showing…
Aug 25, 2024, 09:29 | Insight
Rahul Banerjee: Fascinating Multiple Myeloma results of MajesTEC-1 in BCMA-exposed patients
Rahul Banerjee shared a post by Robert Z. Orlowski, Director of Myeloma Section at MD Anderson…
Aug 23, 2024, 13:45 | Insight
Myeloma Paper of the Day, August 23rd, suggested by Robert Orlowski
Robert Z. Orlowski shared a post on X: "Myeloma Paper of the Day: Study of teclistamab…
Aug 22, 2024, 14:31 | Insight
Myeloma Paper of the Day, August 22th, suggested by Robert Orlowski
Robert Z. Orlowski shared a post on X: "Myeloma Paper of the Day: Extracellular volume (ECV)…
Aug 21, 2024, 13:32 | Insight
Myeloma Paper of the Day, August 21th, suggested by Robert Orlowski
Robert Z. Orlowski shared a post on X: "Myeloma Paper of the Day: Haplotype analysis identifies…
Jul 20, 2024, 21:30 | Insight
Rahul Banerjee: ARROW2 was here all this time and just got published in Blood Advances
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by, Robert Z. Orlowski, on X, adding:…
May 27, 2024, 04:03 | Opinion
Rahul Banerjee: My top 10 ASCO 24 multiple myeloma abstracts
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
May 18, 2024, 15:37 | Insight
Myeloma Paper of the Day, May 18th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Myeloma patients with long remission post-ASCT…
May 8, 2024, 12:49 | Blog
Robert Z. Orlowski: Honored to be named among the inaugural group of Highly Ranked Scholars
Robert Z. Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared a post on…
Apr 9, 2024, 17:56 | Insight
Myeloma Paper of the Day - Robert Z. Orlowski
Robert Z. Orlowski, Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma…
Mar 27, 2024, 00:40 | Insight
Robert Z. Orlowski: Nice review of tumor-intrinsic and -extrinsic resistance mechanisms to T-cell engagers
Robert Z. Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, posted on X/Twitter:…
Feb 29, 2024, 19:11 | Insight
Robert Z. Orlowski: Myeloma Paper of the Day
Robert Z. Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X/Twitter:…
Feb 14, 2024, 13:50 | Drugs
Robert Z. Orlowski: Myeloma Paper of the Day
Robert Z. Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, posted on X/Twitter:…
All: 25 Posts: 1 - 100
Special Coverage